Temporal regulation of EGF signalling networks by the scaffold protein Shc1-Reference-Cited by-同舟云学术

Temporal regulation of EGF signalling networks by the scaffold protein Shc1

Published:2013-07 Issue:7457 Volume:499 Page:166-171
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Zheng Yong,Zhang Cunjie,Croucher David R.,Soliman Mohamed A.,St-Denis Nicole,Pasculescu Adrian,Taylor Lorne,Tate Stephen A.,Hardy W. Rod,Colwill Karen,Dai Anna Yue,Bagshaw Rick,Dennis James W.,Gingras Anne-Claude,Daly Roger J.,Pawson Tony

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature12308.pdf

Reference41 articles.

1. Good, M. C., Zalatan, J. G. & Lim, W. A. Scaffold proteins: hubs for controlling the flow of cellular information. Science 332, 680–686 (2011)

2. Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134 (2010)

3. Uhlik, M. T. et al. Structural and evolutionary division of phosphotyrosine binding (PTB) domains. J. Mol. Biol. 345, 1–20 (2005)

4. Luzi, L., Confalonieri, S., Di Fiore, P. P. & Pelicci, P. G. Evolution of Shc functions from nematode to human. Curr. Opin. Genet. Dev. 10, 668–674 (2000)

5. van der Geer, P., Wiley, S., Gish, G. D. & Pawson, T. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6, 1435–1444 (1996)

Cited by 249 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrafast and Chemoselective Biotinylation of Living Cell Surfaces for Time-Resolved Surfaceome Analysis;Analytical Chemistry;2024-08-28

2. IGPR-1 is phosphorylated on the immunoreceptor tyrosine-based motif, stimulates AKT pathway and supports melanoma growth;2024-08-19

3. Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma;Nature Communications;2024-02-15

4. Fudging the volcano-plot without dredging the data;Nature Communications;2024-02-15

5. Feed-forward stimulation of CAMK2 by the oncogenic pseudokinase PEAK1 generates a therapeutically ‘actionable’ signalling axis in triple negative breast cancer;2024-02-15